The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients.
Kahan
B D
BD
University of Texas Medical School, Department of Surgery, Houston 77030.
Dunn
J
J
Fitts
C
C
Van Buren
D
D
Wombolt
D
D
Pollak
R
R
Carson
R
R
Alexander
J W
JW
Chang
C
C
Choc
M
M
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013997:Time Factors
D016572:Cyclosporine; D003404:Creatinine; D000410:Alanine Transaminase; D001663:Bilirubin